Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 12/2007

01-12-2007 | Case Report

Churg-Strauss syndrome triggered by hyposensitization to Alternaria fungus

Authors: C. Serna-Candel, O. Moreno-Perez, V. Soriano, A. Martínez

Published in: Clinical Rheumatology | Issue 12/2007

Login to get access

Abstract

Churg-Strauss syndrome is a systemic vasculitis of unknown ethiology. Exposure to putative triggers have been described. We report a case of Churg-Strauss syndrome developing after specific immunotherapy with Alternaria fungus.
Literature
1.
2.
Guillevin L, Cohen P, Gayraud M et al (1999) Churg-Strauss syndrome. Clinical study and long term follow up of 96 patients. Medicine 78:26–37CrossRefPubMed
3.
Gross WL (2002) Churg-Strauss syndrome: update on recent developments. Curr Opin Rheumatol 14:11–14CrossRefPubMed
4.
Vanoli M, Gambini D, Scorza R (1998) A case of Churg-Strauss vasculitis after hepatitis B vaccination. Curr Opin Rheumatol 57(4):256–257
5.
Mouthon L, Khaled M, Cohen P et al (2001) Antigen inhalation as a triggering factor in systemic small-sized-vessel vasculitis. Four cases. Ann Med Interne Suppl (Paris) 152:152–156
6.
Abril A, Calamia KT, Cohen MD (2003) The Churg Strauss syndrome (Allergic Granulomatous Angiitis): review and Update. Semin Arthritis Rheum 33:106–114CrossRefPubMed
7.
Phanuphak P, Kohler PF (1980) Onset of Polyarteritis Nodosa during allergic hyposensitization treatment. Am J Med 68:479–485CrossRefPubMed
8.
Guillevin L, Guittard T, Bletry O et al (1987) Systemic necrotizing angiitis with asthma: causes and precipitating factors in 43 cases. Lung 165:165–172CrossRefPubMed
9.
Metadata
Title
Churg-Strauss syndrome triggered by hyposensitization to Alternaria fungus
Authors
C. Serna-Candel
O. Moreno-Perez
V. Soriano
A. Martínez
Publication date
01-12-2007
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 12/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0680-4

Other articles of this Issue 12/2007

Clinical Rheumatology 12/2007 Go to the issue

Original Article

Soluble receptor activator of NFkappa B-ligand and osteoprotegerin in rheumatoid arthritis - relationship with bone mineral density, disease activity and bone turnover

Case Report

Watch out for ‘pins and needles’ in hands—it may be a case of gout

Original Article

A 10-day course of SPA therapy is beneficial for people with severe knee osteoarthritis

Case Report

Accessory navicular bone: when ankle pain does not originate from the ankle

Letter to the Editor

Pyoderma gangrenosum developing during therapy with TNF-alpha antagonists in a patient with rheumatoid arthritis

Case Report

The role of PET/CT in Cogan’s syndrome
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits